Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07298135Not ApplicableActive Not Recruiting

A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults

Role: collaborator

NCT07102680Not ApplicableActive Not Recruiting

A Randomized, Placebo Controlled Trial of L Max in Healthy Adult Athletes

Role: collaborator

NCT07493239Not ApplicableRecruiting

A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health

Role: collaborator

NCT07333885Not ApplicableRecruiting

Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)

Role: collaborator

All 4 trials loaded